Sign in
Explore the registryTrack Mrna-4157's trials

KEYNOTE-603

Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors

MRNA-4157OngoingActive not recruitingPhase 1Open NCT03313778 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…